Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-15Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue
-
CLINICAL_TRIALS study record update · 2026-10-15Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue
-
CLINICAL_TRIALS study results posted · 2026-09-25A Single Arm, Open Label Multicentre Extension Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Patients With Multiple Sclerosis Previously Enrolled In A F. Hoffmann-La Roche Sponsored Ocrelizumab Phase IIIb/IV Clinical Trials
-
CLINICAL_TRIALS study results posted · 2026-09-23Aerobic Exercise to Improve Mobility in Multiple Sclerosis: Optimizing Design and Execution for a Full-scale Multimodal Remyelination Clinical Trial
-
CLINICAL_TRIALS study results posted · 2026-08-07The Feasibility and Efficacy of a Remotely Delivered Exercise Training Intervention for the Hispanic/Latino Community With Multiple Sclerosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study results posted · 2026-07-28Cladribine Tablets: Collaborative Study to Evaluate the Impact On Central Nervous System Biomarkers in Multiple Sclerosis
-
CLINICAL_TRIALS study results posted · 2026-06-09Feasibility of Low-load Resistance Training Using Blood Flow Restriction for People With Multiple Sclerosis and Marked Mobility Restriction
-
CLINICAL_TRIALS study results posted · 2026-06-05A Randomized, Double-Blind, Placebo-Controlled, First-in-Human, Single and Multiple Ascending Dose Study of MTR-601 in Healthy Volunteers.
-
CLINICAL_TRIALS study record update · 2026-04-27Neurocognitive Musical Screening and Therapeutic Innovation: A Crossover Randomized Controlled Pilot Study
-
CLINICAL_TRIALS study record update · 2026-04-27A Multiple-center, Non-randomized, Open-label, Adaptive, Single-ascending Dose (Part 1 and Part 2) and Multiple-ascending Dose (Part 3) Parallel, Phase IB Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of RO7121932 Following Intravenous (Parts 1) and Subcutaneous Administration (Parts 2 and 3) in Participants With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-04-27A Phase II, Randomized, Open-label, Parallel Group, Multicenter Study to Assess Bioequivalence of Two Subcutaneous Formulations of Ocrelizumab in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-04-27Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics
-
CLINICAL_TRIALS study record update · 2026-04-27SurfSubQ - A Prospective Longitudinal Multicenter Observational Study to Investigate Neurofilament Light Chain Levels and Patient Satisfaction After Subcutaneous Ocrelizumab Administration in Persons With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-04-27A Study Investigating Drivers of Physician and Patient Satisfaction Towards Treatment
-
CLINICAL_TRIALS study record update · 2026-04-24Comprehensive Multimodal Analysis of Patients With Neuroimmunological Diseases of the CNS
-
CLINICAL_TRIALS study record update · 2026-04-24Clinical Investigation to Validate the Safety and Performance of Integrating Functional Electrical Stimulation Into the ABLE Exoskeleton
-
CLINICAL_TRIALS study record update · 2026-04-23"Evaluation of Usability and Safety of the Self-balancing Walking System Atalante in Patients With Multiple Sclerosis"
-
CLINICAL_TRIALS study record update · 2026-04-23Exercise Training for People With Advanced Multiple Sclerosis: A Feasibility Study to Inform Intervention Development
-
CLINICAL_TRIALS study record update · 2026-04-23The Relationship Between Mood, Insomnia Severity, and Caregiver Burden in Caregivers of Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-04-23Supporting Mental Health in Daily Life After the Diagnosis of Multiple Sclerosis: the Role of Flow Experience and Mindfulness
-
CLINICAL_TRIALS study record update · 2026-04-22Benefits of a High-Intensity Exercise Program With Immersive Virtual Reality in Multiple Sclerosis: Exploratory Study
-
CLINICAL_TRIALS study record update · 2026-04-22Percutaneous Versus Transcutaneous Nerve Stimulation of the Median, Radial, and Ulnar Nerves: Effects on Hand Function in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-04-22An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of CD20 Monoclonal Antibody Combined With NK042 Cell Injection in the Treatment of Multiple Sclerosis (MS).
-
CLINICAL_TRIALS study record update · 2026-04-22A Phase 1b, Open-label, Multi-center, Randomized Study Evaluating the Safety and Tolerability of AZD0120, an Autologous CD19/BCMA Targeting Chimeric Antigen Receptor T-cells, in Adults With Refractory Relapsing or Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-04-22Clinical Trial to Compare Conventional Multidisciplinary Gait Rehabilitation With the Atalante Self-balancing Walking System in Patients With Multiple Sclerosis